Full Text View
Tabular View
No Study Results Posted
Related Studies
Early Detection of Breast Cancer Using Tomosynthesis Imaging
This study is currently recruiting participants.
Study NCT00637598   Information provided by Duke University
First Received: March 12, 2008   Last Updated: May 11, 2009   History of Changes

March 12, 2008
May 11, 2009
November 2004
March 2010   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00637598 on ClinicalTrials.gov Archive Site
 
 
 
Early Detection of Breast Cancer Using Tomosynthesis Imaging
Early Detection of Breast Cancer Using Tomosynthesis Imaging

The purpose is to develop digital tomosynthesis to improve the detection of breast cancers. The aims are optimizing digital mammography and tomosynthesis acquisition, creating visualization tools, prospective pilot studies to evaluate radiologist performance, and computer-aided detection.

Finding breast cancer early has been shown to improve the chance of survival. Mammography (x-ray imaging of the breast) helps find breast cancer early. Some breast cancers, however, are not seen on mammography, which creates two-dimensional images for the radiologist to see. The goal of this study is to make a breast tomosynthesis or tomosynthesis 3D (three-dimensional) x-ray system by taking x-ray images from many angles. This is similar to a CAT (computerized axial tomography) scan for the breast and can give radiologists 3D information so that they can find breast cancers which might otherwise be hidden from view.

 
Observational
Case-Only, Prospective
Breast Neoplasms
Radiation: Mammography and tomosynthesis imaging
This is a case-only study with only one group/cohort. All women receive both mammography and tomosynthesis imaging.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
350
March 2010
March 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

All Subjects accepted for this clinical study must:

  • Be already scheduled to undergo screening mammography, diagnostic mammography, or breast biopsy for standard clinical indications
  • Provide written informed consent
  • Be able to communicate effectively with clinical study personnel.

Exclusion Criteria:

Subjects with any of the following conditions will be excluded from this clinical study:

  • Childbearing potential and subject refuses serum pregnancy test or test result is positive.
Female
 
Yes
Contact: Joseph Y Lo, PhD 919-684-7763 joseph.lo@duke.edu
United States
 
NCT00637598
Joseph Lo,PhD, Duke University Health System, Duke University School of Medicine
6503, 6024
Duke University
 
Principal Investigator: Joseph Y Lo, PhD Duke University Health System
Duke University
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP